Blood products within the responsibility of the Paul-Ehrlich-Institut (PEI) comprise human blood components for transfusion and proteins either derived from human plasma or biotechnologically engineered.
to the top
The Paul-Ehrlich-Institut is an Agency of the German Federal Ministry of Health.
Its research and control activities promote the quality, efficacy and safety of biological medicinal products.
© Paul-Ehrlich-Institut 2022